Boxer Capital, Llc Odonate Therapeutics, Inc. (ODTC) insider trading activity

Boxer Capital, LLC is > 10% Shareholder of Odonate Therapeutics, Inc.. Currently has a direct ownership of 4.21 Million shares of ODTC, which is worth approximately $71.7 Billion. The most recent transaction as insider was on Nov 24, 2021, when has been sold 200,000 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $314,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.21M

0% 3M change

0% 12M change

Total Value Held $71.7 Billion

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 24 2021	SELL Open market or private sale	$314,000 $1.57 p/Share	200,000 Reduced 4.54%	4,207,086 Common Stock
Nov 22 2021	SELL Open market or private sale	$310,000 $1.55 p/Share	200,000 Reduced 4.34%	4,407,086 Common Stock
Nov 19 2021	SELL Open market or private sale	$276,000 $1.84 p/Share	150,000 Reduced 3.15%	4,607,086 Common Stock
Nov 18 2021	SELL Open market or private sale	$487,500 $1.95 p/Share	250,000 Reduced 4.99%	4,757,086 Common Stock
Nov 17 2021	SELL Open market or private sale	$1,302,000 $2.17 p/Share	600,000 Reduced 10.7%	5,007,086 Common Stock
Dec 30 2020	BUY Open market or private purchase	$1,746,000 $17.46 p/Share	100,000 Added 1.75%	5,607,086 Common Stock
Dec 28 2020	BUY Open market or private purchase	$5,103,000 $17.01 p/Share	300,000 Added 5.17%	5,507,086 Common Stock

Sep 29 2020	BUY Open market or private purchase	$1,717,760 $14.08 p/Share	122,000 Added 2.29%	5,207,086 Common Stock
Sep 28 2020	BUY Open market or private purchase	$1,214,396 $13.03 p/Share	93,200 Added 1.8%	5,085,086 Common Stock
Sep 09 2020	BUY Open market or private purchase	$1,232,720 $15.2 p/Share	81,100 Added 1.6%	4,991,886 Common Stock
Sep 08 2020	BUY Open market or private purchase	$276,172 $14.69 p/Share	18,800 Added 0.38%	4,910,786 Common Stock
Sep 04 2020	BUY Open market or private purchase	$1,862,739 $14.89 p/Share	125,100 Added 2.49%	4,891,986 Common Stock
Aug 28 2020	BUY Open market or private purchase	$20,000,003 $14.25 p/Share	1,403,509 Added 22.75%	4,766,886 Common Stock
Jun 26 2019	BUY Open market or private purchase	$9,999,990 $26.0 p/Share	384,615 Added 10.26%	3,363,377 Common Stock
Dec 26 2018	BUY Open market or private purchase	$311,750 $12.47 p/Share	25,000 Added 0.83%	2,978,762 Common Stock
Dec 21 2018	BUY Open market or private purchase	$1,347,000 $13.47 p/Share	100,000 Added 3.27%	2,953,762 Common Stock
Oct 24 2018	BUY Open market or private purchase	$394,849 $14.72 p/Share	26,824 Added 0.93%	2,853,762 Common Stock
Mar 26 2018	BUY Open market or private purchase	$754,096 $22.41 p/Share	33,650 Added 1.18%	2,826,938 Common Stock
Mar 23 2018	BUY Open market or private purchase	$1,028,914 $23.96 p/Share	42,943 Added 1.51%	2,793,288 Common Stock
Mar 22 2018	BUY Open market or private purchase	$490,143 $20.94 p/Share	23,407 Added 0.84%	2,750,345 Common Stock
Dec 06 2017	BUY Open market or private purchase	$9,999,984 $24.0 p/Share	416,666 Added 13.25%	2,726,938 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

TYRA

Tyra Biosciences, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

BCL